Skip to main content
OpenTrials
Completed

NCT Number: NCT02908828

Calanus Oil Supplementation and Maximal Oxygen Uptake

Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton species in the marine food web in the Norwegian Sea. Copepods constitute the largest renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now developed knowledge and technology for sustainable harvesting of this "new" resource. The purpose of this study is to investigate whether Calanus copepod oil supplementation has an equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in mice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

30 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institutt for Medisinsk Biologi, UiT Norges arktiske universitet, Tromsø, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • in good health
  • Body mass index (BMI) between 18,5 and 29,9

Exclusion criteria

  • Medical condition limiting VO2max (COPD or asthma).
  • diagnosed coronary artery disease
  • Any other significant medical condition
  • medication effecting exercise capacity (e.i. betablockers)
  • Pregnancy
  • Participation in other clinical trials
  • Shellfish allergies
  • Systolic blood pressure > 170 mmHG, or diastolic BP > 105 mmHG.
  • contraindications for maximal exercise testing

Treatment and study plan

Calanus oil

Dietary Supplement

placebo dietary oil

Dietary Supplement

Primary outcomes

  1. maximal oxygen uptake (VO2max)

    Time frame: 6 months

    Measured with indirect calorimetry at a treadmill (running/walking) with gradually increasing work load until exhaustion. After 10-15 min with warmup at 70% of maximal heart rate, work load will be increased every 1-2 minute and the changes maximal oxygen uptake (VO2) will be recorded automatically.

Secondary outcomes

  1. Body composition (InBody, Japan)

    Time frame: 6 months

  2. Self-reported physical activity

    Time frame: 6 months

    assessed with International Physical Activity Questionnaire (IPAQ) short version

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • Calanus
  • University of Tromso

Registry information

Official study title

Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 21, 2016
Registry last updated
Sep 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.